Low density lipoprotein for cytotoxic drug targeting: improved activity of elliptinium derivative against B16 melanoma in mice.

[1]  D. Lesieur,et al.  Low-density lipoprotein for delivery of an acrylophenone antineoplastic molecule into malignant cells. , 1992, Cancer research.

[2]  T. V. Berkel,et al.  PROLONGED SERUM HALF-LIFE OF ANTINEOPLASTIC DRUGS BY INCORPORATION INTO THE LOW DENSITY LIPOPROTEIN , 1990 .

[3]  S. Vitols,et al.  Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells. In vitro and in vivo studies of a drug-lipoprotein complex. , 1990, British Journal of Cancer.

[4]  G. Favre,et al.  Comparative study of the incorporation of ellipticine-esters into low density lipoprotein (LDL) and selective cell uptake of drug--LDL complex via the LDL receptor pathway in vitro. , 1990, Biochemical pharmacology.

[5]  K. Einarsson,et al.  Low density lipoprotein receptor-binding activity in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Gahrton,et al.  Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Freeman,et al.  Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils , 1990, Nature.

[8]  M. Bally,et al.  Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors. , 1990, Cancer research.

[9]  G. Canti,et al.  Assimilation of LDL by experimental tumours in mice. , 1989, Biochimica et biophysica acta.

[10]  G. Favre,et al.  Preparation of low density lipoprotein-9-methoxy-ellipticin complex and its cytotoxic effect against L1210 and P 388 leukemic cells in vitro. , 1989, European journal of cancer & clinical oncology.

[11]  A. Chait,et al.  Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells. , 1988, The Journal of biological chemistry.

[12]  L. Schook,et al.  Delivery of Lipophilic Drugs Using Lipoproteins a , 1987, Annals of the New York Academy of Sciences.

[13]  P. Gros,et al.  Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl. , 1987, Cancer research.

[14]  D. Erkelens,et al.  Effect of the composition of very low and low density lipoproteins on the rate of cholesterylester transfer from high density lipoproteins in man, studied in vitro , 1987, European journal of clinical investigation.

[15]  G. Schonfeld,et al.  Hypolipidemic therapy modulates expression of apolipoprotein B epitopes on low density lipoproteins. Studies in mild to moderate hypertriglyceridemic patients. , 1987, Journal of lipid research.

[16]  R. L. Ruben,et al.  Semiautomated colorimetric assay for in vitro screening of anticancer compounds. , 1987, Cancer treatment reports.

[17]  S. Vitols,et al.  Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice. , 1986, Cancer research.

[18]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[19]  R J Havel,et al.  Introduction to the plasma lipoproteins. , 1986, Methods in enzymology.

[20]  Y. Poumay,et al.  Rapid preparative isolation of concentrated low density lipoproteins and of lipoprotein-deficient serum using vertical rotor gradient ultracentrifugation. , 1985, Journal of lipid research.

[21]  G. Gahrton,et al.  HYPOCHOLESTEROLAEMIA IN MALIGNANCY DUE TO ELEVATED LOW-DENSITY-LIPOPROTEIN-RECEPTOR ACTIVITY IN TUMOUR CELLS: EVIDENCE FROM STUDIES IN PATIENTS WITH LEUKAEMIA , 1985, The Lancet.

[22]  S. Eisenberg.  Preferential enrichment of large-sized very low density lipoprotein populations with transferred cholesteryl esters. , 1985, Journal of lipid research.

[23]  J. Parks,et al.  Fusion of low density lipoproteins with cholesterol ester-phospholipid microemulsions. Prevention of particle fusion by apolipoprotein A-I. , 1985, The Journal of biological chemistry.

[24]  C. McArdle,et al.  Low-density lipoprotein metabolism in mice with soft tissue tumours. , 1984, Biochimica et biophysica acta.

[25]  A. Chait,et al.  Low-density lipoproteins modified by lipid transfer protein have altered biological activity. , 1984, Biochimica et biophysica acta.

[26]  S. Yanovich,et al.  Preparation and interaction of a low-density lipoprotein:daunomycin complex with P388 leukemic cells. , 1984, Cancer research.

[27]  D. B. Zilversmit,et al.  Inter-relationship of lipids transferred by the lipid-transfer protein isolated from human lipoprotein-deficient plasma. , 1983, The Journal of biological chemistry.

[28]  D. Small,et al.  The phase behavior of triolein, cholesterol, and lecithin emulsions , 1982 .

[29]  C. Packard,et al.  Measurement of receptor-independent lipoprotein catabolism using 1,2 cyclohexanedione-modified low density lipoprotein. , 1982, Journal of lipid research.

[30]  E. Simpson,et al.  Low-density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms. , 1981, American journal of obstetrics and gynecology.

[31]  H. G. Morgan,et al.  Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism. , 1980, The New England journal of medicine.

[32]  C. Packard,et al.  Receptor-mediated low density lipoprotein catabolism in man. , 1979, Journal of lipid research.

[33]  M. Krieger,et al.  Reconstituted low density lipoprotein: a vehicle for the delivery of hydrophobic fluorescent probes to cells. , 1979, Journal of supramolecular structure.

[34]  R. Mahley,et al.  Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins. , 1977, The Journal of biological chemistry.

[35]  M. Brown,et al.  The low-density lipoprotein pathway and its relation to atherosclerosis. , 1977, Annual review of biochemistry.

[36]  M. Brown,et al.  Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. , 1974, The Journal of biological chemistry.

[37]  J. Patsch,et al.  Separation of the main lipoprotein density classes from human plasma by rate-zonal ultracentrifugation. , 1974, Journal of lipid research.

[38]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[39]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.